Payer Overview
ELIXIR INS CO: Niche Health Insurance Payer with Regional Concentration
ELIXIR INS CO is a niche health insurance payer with a limited national footprint, operating in 13 states and writing a total premium of $9.5 million. The payer's average market share is 0.77%, with its highest share in Delaware (7%), where it ranks 46th in the market. In all other states, ELIXIR INS CO's market share is below 2%, and it does not hold a top-three position in any state. The estimated total insured member count is 1,618, with the largest populations found in Delaware, Florida, Illinois, and New Hampshire. For providers, ELIXIR INS CO represents a minor contracting opportunity except in Delaware, where its presence is more substantial. Providers should be aware that ELIXIR INS CO's member base is concentrated in a few states, and its impact on patient mix and reimbursement is limited nationally. Contracting strategies should focus on Delaware and other states with higher member counts, while in other regions, ELIXIR INS CO is unlikely to be a major payer partner.
Payer Overview
ELIXIR INS CO operates in 13 states with a total premium volume of $9,526,955. The payer's average market share across these states is 0.77%, with a maximum state share of 7% in Delaware. ELIXIR INS CO is not ranked #1 in any state, nor does it appear in the top 3 in any market. The estimated national member count is 1,618. Delaware is the only state where ELIXIR INS CO holds a notable market share, while in other states, its presence is minimal.
National Market Presence
National Market Footprint
| State | Market Rank | Market Share (%) | Premium Written ($) | Estimated Members |
|---|---|---|---|---|
| Delaware | 46 | 7 | 2,122,445 | 540 |
| New Hampshire | 56 | 2 | 1,033,770 | 199 |
| Connecticut | 80 | 1 | 697,548 | 136 |
| District Of Columbia | 85 | 0 | 93,235 | 6 |
| Florida | 108 | 0 | 2,798,825 | 318 |
| Illinois | 124 | 0 | 1,375,258 | 199 |
| Michigan | 124 | 0 | 579,830 | 83 |
| Mississippi | 109 | 0 | 351,480 | 55 |
| New York | 105 | 0 | 326,652 | 55 |
| Rhode Island | 123 | 0 | 2,209 | 0 |
| Vermont | 113 | 0 | 3,300 | 1 |
| Washington | 114 | 0 | 116,466 | 20 |
| Wyoming | 118 | 0 | 25,937 | 7 |
ELIXIR INS CO's national footprint is limited, with presence in 13 states and a total premium volume of $9.5 million. The payer's market share is highest in Delaware (7%), followed by New Hampshire (2%) and Connecticut (1%). In all other states, market share is negligible. Estimated member counts are concentrated in Delaware, Florida, Illinois, and New Hampshire, with other states having minimal populations.
This concentration means that ELIXIR INS CO is a minor player in most markets, except Delaware, where it has a more substantial presence. For provider contracting, ELIXIR INS CO is only a significant consideration in Delaware and, to a lesser extent, in states with higher member counts. Nationally, the payer's impact on provider networks and reimbursement is limited, and multi-state providers will find ELIXIR INS CO relevant only in select regions.
State-by-State Market Position
ELIXIR INS CO's strongest presence is in the Northeast, particularly Delaware, New Hampshire, and Connecticut. Delaware is the only state where the payer holds a notable market share (7%), while New Hampshire and Connecticut have modest shares (2% and 1%, respectively). The Southeast (Florida, Mississippi) and Midwest (Illinois, Michigan) show higher premium volumes but negligible market share, indicating a limited competitive position.
The geographic distribution is highly uneven, with most states showing minimal market share and member counts. For multi-state provider groups, ELIXIR INS CO is only relevant in Delaware and possibly New Hampshire and Connecticut. In other regions, the payer's presence is too small to impact contracting or network strategy. Providers should focus their engagement with ELIXIR INS CO in states where member concentration and market share are highest, while deprioritizing it elsewhere.
Estimated Member Demographics
Estimated Member Demographics
| Age Band | Delaware | Florida | Illinois | New Hampshire | Connecticut | Michigan | Mississippi | New York | Washington | Wyoming | District Of Columbia | Vermont | National Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Under 6 | 30 | 16 | 12 | 10 | 8 | 5 | 3 | 3 | 1 | 0 | 0 | 0 | 89 |
| 6–18 | 79 | 43 | 31 | 27 | 20 | 13 | 8 | 8 | 3 | 1 | 1 | 0 | 235 |
| 19–25 | 44 | 28 | 19 | 19 | 13 | 8 | 6 | 5 | 2 | 1 | 1 | 1 | 144 |
| 26–34 | 61 | 38 | 25 | 23 | 16 | 10 | 7 | 7 | 3 | 1 | 1 | 1 | 191 |
| 35–44 | 69 | 45 | 29 | 26 | 18 | 11 | 8 | 8 | 3 | 1 | 1 | 1 | 220 |
| 45–54 | 70 | 47 | 28 | 27 | 19 | 11 | 8 | 7 | 3 | 1 | 1 | 1 | 222 |
| 55–64 | 84 | 51 | 28 | 34 | 22 | 12 | 8 | 8 | 3 | 1 | 1 | 1 | 251 |
| 65–74 | 61 | 26 | 15 | 19 | 11 | 8 | 5 | 5 | 2 | 1 | 0 | 0 | 154 |
| 75+ | 42 | 23 | 11 | 13 | 8 | 6 | 3 | 3 | 1 | 0 | 0 | 0 | 112 |
Nationally, the largest age bands are 55–64 (251 members), 45–54 (222 members), and 35–44 (220 members), indicating a strong adult focus. The pediatric population (Under 6 and 6–18) is present but smaller, while seniors (65–74 and 75+) are a modest segment.
Delaware stands out with the highest member counts across all age bands, especially in the older adult and senior categories. Florida also shows a relatively higher senior population. States like Wyoming, Vermont, and District Of Columbia have very small member counts, with minimal representation across age bands. This distribution suggests that ELIXIR INS CO's member base is concentrated in a few states, with a demographic skew toward adults and pre-seniors.
Estimated Members by State
ELIXIR INS CO's estimated member distribution is highly concentrated in a handful of states. Delaware leads with 540 members, followed by Florida (318), Illinois (199), and New Hampshire (199). Other states such as Connecticut (136), Michigan (83), Mississippi (55), and New York (55) have moderate member counts. The remaining states, including Washington, Wyoming, District Of Columbia, and Vermont, have very small member populations, often fewer than 20 members.
This geographic concentration does not always align with market share rank. For example, Delaware has both the highest market share and member count, while Florida, despite a low market share, has a substantial member base due to higher premium volume. Providers in states with larger ELIXIR INS CO populations should be aware of the payer's presence and potential impact on patient mix and contracting opportunities. In states with minimal member counts, ELIXIR INS CO is unlikely to be a significant contracting partner, and providers may prioritize other payers for network strategy.
Provider & Care Delivery Implications
ELIXIR INS CO's member demographic profile is weighted toward adults, with the largest age bands being 55–64, 45–54, and 35–44. This suggests providers should expect a care mix focused on chronic disease management, preventive screenings, and adult primary care. Pediatric members (Under 6 and 6–18) are present but represent a smaller proportion, indicating less demand for pediatric specialty services compared to adult care.
The significant presence in the 55–64 age band points to a higher likelihood of chronic conditions such as diabetes, hypertension, and cardiovascular disease. Providers contracting with ELIXIR INS CO should be prepared for care coordination, medication management, and preventive services targeting these populations. The relatively modest senior (65+) population means geriatric care is less prominent, but still relevant in states like Delaware and Florida where older age bands are more represented.
Revenue cycle and reimbursement strategies should account for the adult-heavy mix, with a focus on services that address chronic disease, preventive care, and outpatient management. Pediatric and senior care will be less central, but providers in states with higher youth or senior populations (e.g., Delaware, Florida) may see more demand for those services. Understanding this demographic mix is crucial for optimizing care delivery and negotiating contracts with ELIXIR INS CO.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.